![Geraldine Rodgers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Geraldine Rodgers
Corporate Officer/Principal chez Ampika Ltd.
Profil
Dr. Geraldine Rodgers is Head of Seed Funds at Cambridge Enterprise Ltd.
where she is responsible for biotechnology investments.
She has completed investments into Akubio, Smart Holograms, DanioLabs, Lumora, DeltaG, British Stem Cell Registry, Ampika, Psynova, Sentinel Oncology and CellCentric.
She serves as a Non-executive Board member on five Fund companies.
She is on the Board of Directors at Sentinel Oncology Ltd.
and Ampika Ltd.
She joined the University of Cambridge in 1994.
She worked first for Professor Chris Lowe at the Institute of Biotechnology and then moved to work in technology transfer at the former Wolfson Industrial Liaison Office (now part of Cambridge Enterprise).
Dr. Rodgers has a first degree in Microbiology, a PhD in Biochemistry and holds the FSA full Investment Management Certificate.
Postes actifs de Geraldine Rodgers
Sociétés | Poste | Début |
---|---|---|
Ampika Ltd.
![]() Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Anciens postes connus de Geraldine Rodgers
Sociétés | Poste | Fin |
---|---|---|
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Director of Investments | 31/03/2011 |
Sentinel Oncology Ltd.
![]() Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Finance |
Ampika Ltd.
![]() Ampika Ltd. Drugstore ChainsRetail Trade Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom. | Retail Trade |
Sentinel Oncology Ltd.
![]() Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |